Novel therapeutic strategies for patients with triple-negative breast cancer

Triple-negative breast cancer (TNBC) represents a very heterogeneous group of breast diseases. Currently, the backbone of therapy for TNBC is mainly chemotherapy as there are no effective specific targeted agents approved to treat TNBC. Despite initial responses to chemotherapy, resistance frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun-Fei, Liu, Jia, Wang, Yu, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085278/
https://www.ncbi.nlm.nih.gov/pubmed/27799799
http://dx.doi.org/10.2147/OTT.S105716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085278/
https://www.ncbi.nlm.nih.gov/pubmed/27799799
http://dx.doi.org/10.2147/OTT.S105716

Ejemplares similares